In its review a biotech wheat produced in Argentina, the U.S. Food and Drug Administration said it has “no further questions” regarding its safety. Bioceres Crop Solutions developed the drought tolerant HB4 wheat and says the FDA statement is a “key step toward commercialization in the United States.” In a joint statement, the National Association of Wheat Growers and U.S. Wheat Associates emphasized the FDA has not approved any transgenic wheat for planting in the U.S. However, the U.S. wheat groups said they recognize the benefits of modern biotechnology.
Subscribe to RRFN
Get a weekly digest from RRFN to stay up-to-date on all the latest news in agriculture.